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Abstract: With the cheapening of mass sequencing techniques and the rise of computer technologies,
capable of analyzing a huge amount of data, it is necessary nowadays that both branches mutually
benefit. Transcriptomics, in this case, is a branch of biology focused on the study of mRNA molecules,
among others. The quantification of these molecules gives us information about the expression that a
gene is having at a given moment. Having information on the expression of the approximately 20,000
genes harbored by human beings is a really useful source of information for the study of certain
conditions and/or pathologies. In this work, patient expression -omic data data have been used to
offer a new analysis methodology through Machine Learning. The results of this methodology were
compared with a conventional methodology to observe how they differed and how they resembled
each other. These techniques, therefore, offer a new mechanism for the search of genetic signatures
involved, in this case, with cancer.
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1. Introduction
Having access to the expression of the whole spectrum of genes of an individual gives us the
possibility to identify specific expression patterns of a condition and/or pathology. Nowadays, with the
use of Machine Learning (ML) techniques, and with the large amount of data available for free, it is
possible to use these techniques to extract new knowledge from the analysis. ML is able to identify
expression patterns and/or gene subgroups that conventional techniques are not able to detect. For this
reason, the detection of differential genetic expression patterns has been proposed for two groups of
patients: patients with colon cancer and patients with lung cancer. The analysis will be carried out
using two different approaches: conventional statistics and ML. Our work was published before in
“Machine Learning Paradigms. Learning and Analytics in Intelligent Systems” [1].
2. Results
In this paper, a new way of analyzing gene expression data is proposed. The use of ML offer the
possibility of widening the search space in terms of genes of interest. Unlike conventional analysis
techniques, ML techniques allow working with hundreds and thousands of variables. The final
objective of the analysis is to find those genes that have a differential expression between two patient
populations, labeled as COAD and LUAD.
2.1. Conventional Analysis of Differential Gene Expression
In order to decide whether, for a given gene, there is a significant statistical difference in the
number of mapped readings of that gene for different biological conditions, a statistical test should
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be performed, where the count of readings should be modeled to a certain distribution. Once the
distribution that follow the data has been defined, and in this case, the dispersion of the data has been
calculated, the differential expression of the transcripts is determined by the corresponding statistical
tests for hypothesis contrast. Today there are different implementations in several statistical software
that execute all this analysis in a simple way for the researcher. In this work we have used one of the
most used in the field, called edgeR [2] package. According with a classical approach, Table 1 shows
the 10 genes that have obtained the most significant values through classical analysis.
Table 1. Classical approach. ten genes with the higher impact between conditions.
Gene Name p-Value
ITGA6 2.605237 × 10−245
AXIN2 4.065388 × 10−203
NOS2 1.848360 × 10−185
MYC 4.409724 × 10−171
TCF7 3.930353 × 10−163
COL4A3 2.205117 × 10−162
COL4A4 1.548193 × 10−138
TCF7L1 2.527959 × 10−110
PIK3R2 6.857479 × 10−103
BBC3 2.481885 × 10−99
2.2. Data Analysis Using Machine Learning
On the other hand, the development of Machine Learning algorithms has greatly benefited the
analysis of complex data, such as genomic data. In this work we have used ML to solve a classification
problem (COAD vs LUAD), providing in this way, a new way to model transcriptomic data and
thus to be able to extract new knowledge and search for new genetic signatures involved in cancer.
The analysis of the importance of the variables gives us a fairly realistic approximation of what is
happening. In Figure 1 we can see how the genes COL4A3 and NOS2 are the most important. On the
other hand, PIK3CD and COL4A4 have hardly any weight in the model. If we compare the Top 10
genes of both approximations we observe coincidences in 7 genes and differences in 3 of them. As far as
the conventional approximation is concerned, this presents significant results for the TCF7L1, PIK3R2
and BBC3 genes that the ML has not detected among the Top 10. For its part, ML techniques added














Figure 1. Variable importance according with the glmnet algorithm.
3. Discussion
The results obtained in this work indicate that ML offer coherent results in comparison with
conventional techniques. The results that are observed shown that for a simple classification problem,
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both approaches reach almost the same results, although it is true that ML techniques may offer
different possibilities when searching for new genetic marks. It is for this reason that the use of these
techniques is considered useful when problems increase in complexity and the spectrum of genes
involved in the pathology, such as cancer, is unknown.
4. Materials and Methods
The data has been downloaded from The Cancer Genome Atlas (TCGA) repository [3] from colon
cancer patients (COAD) and lung cancer patients (LUAD). Due to the great dimensionality of the data
(around 20,000), those genes belonging to specific cellular pathways were selected. In this case, genes
were selected that had been previously identified in the routes related to colon cancer and lung cancer.
For this purpose, the repository KEGG [4] was used, through the package KEGGREST [5] of R [6].
Specifically, the identifiers of pathways hsa05222, hsa05223 and hsa05210 were used, thus reducing
the dimensionality to 173 genes. An univariate method (Kruskal test) were used to rank the genes.
As for the classical approach, the edgeR package [2] has been taken as a reference. A Nested Cross
Validation was used for training the models. In other words, there were two validation phases. Firstly,
a holdout was used for the selection of the best hyperparameters (2/3 for training and 1/3 for testing)
and secondly, a 10-fold CV was used for the validation of the model (we ran 5 times this CV process).
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